The Information Survey: More Than Half of Respondents Take a GLP-1

It’s not exactly news that Ozempic, Wegovy and other GLP-1 drugs are catching on, with some surveys showing nearly 12% of Americans have used the weight loss medications. The Information’s audience seems to be even more gung-ho about taking GLP-1s than the broader population.

More than 50% of the respondents to our recent survey on the topic said they’re currently on a GLP-1 and an additional 4% said they had taken one of the drugs in the past. Those are eye-popping figures that likely reflect the fact that many people in and around Silicon Valley are more affluent than the general population, which makes them less sensitive to the out-of-pocket expense of GLP-1 drugs. And techies also tend to be enthusiastic early adopters of new wellness trends (see our related story here).